Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

CC BY

Saved in:
Bibliographic Details
Main Authors: Marius, Trøseid, José R., Arribas, Lambert, Assoumou
Format: Book
Language:English
Published: Springer 2023
Subjects:
Online Access:https://link.springer.com/article/10.1186/s13054-022-04205-8
https://dlib.phenikaa-uni.edu.vn/handle/PNK/7298
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first